Results for the Quarter ended June 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Deccan Health Care Ltd reported Q1 FY26 standalone revenue from operations of Rs. 2,146.95 lakhs, up about 42.6% from Rs. 1,506.11 lakhs in Q1 FY25. Despite strong top-line growth, profit before tax fell to Rs. 24.72 lakhs from Rs. 30.11 lakhs, and standalone profit after tax declined to Rs. 13.60 lakhs from Rs. 21.25 lakhs. Consolidated revenue rose to Rs. 2,214.64 lakhs with PAT at Rs. 12.35 lakhs, reflecting margin compression as costs like raw materials (Rs. 1,174.46 lakhs) and other expenses scaled faster than profits. The statutory auditor (Keyur Shah & Associates) issued an unmodified limited review report. During the quarter, 3,23,667 equity shares were allotted upon warrant conversions, and Rs. 75 lakhs from lapsed warrants was forfeited.
Strong revenue growth signals demand expansion, but shrinking margins and a PAT drop of roughly 36% (standalone) suggest cost pressures are eating into profitability — a mixed result that may limit near-term positive stock reaction despite the topline beat.